Uncategorized Editor's Note The Joint Commission on June 21 announced new and revised sprinkler head requirements, effective immediately, for critical access hospitals, hospitals, and behavioral healthcare and human services organizations (LS.02.01.35, EP7). The sprinkler head requirement also have been added for ambulatory healthcare occupancies (LS.03.01.35, EP 7) and inpatient hospice facilities…
Editor's Note The Joint Commission posted a reminder on June 16 that applications for the new Bernard J. Tyson National Award program from The Joint Commission and Kaiser Permanente are open until July 8. The award recognizes healthcare organizations and their partners that achieved a measurable, sustained reduction in one…
Editor's Note The Joint Commission and National Quality Forum (NQF), on June 9, announced the recipients of the 2020 John M. Eisenberg Patient Safety and Quality Awards. The awards recognize and honor initiatives in three categories: Innovation in Patient Safety and Quality at the National Level—Veterans Health Administration Rapid Naloxone…
Editor's Note The Joint Commission announced June 2 that Joint Commission Resources, Inc, (JCR) has launched a new subscription-based Digital Learning Center (DLC) to provide on-demand accreditation and compliance courses and content. In addition to JCR’s digital content, which includes webinars, videos, PolicySource, and digital newsletters and e-books, the DLC…
Editor's Note The Food and Drug Administration (FDA), on May 21, identified the recall by Boston Scientific Corporation of its VICI Venous Stent and VICI RDS Venous Stent systems as Class I, the most serious. The recall was initiated because of reports that the stents may migrate or move from…
Editor's Note The Joint Commission, on May 12, listed the top 5 standards most frequently identified as “not compliant” during surveys and reviews from January 1 to December 31, 2020. The top five for accredited hospitals are: NPSG.15.01.01: Reduce the risk for suicide. EP1. IC.02.02.01: The hospital reduces the risk…
Editor's Note Hospira Inc, a Pfizer company, announced May 4 that it is recalling lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 30 mL and lot EG8933 of 1% Lidocaine HCL Injection, USP 30 mL because of mislabeling. A portion of each lot was incorrectly labeled as the other product.…
Editor's Note The Food and Drug Administration (FDA), on April 26, identified the recall by Cordis Corporation of its Precise PRO Rx US Carotid System as Class I, the most serious. The Carotid System is being recalled due to a risk of separation of the atraumatic distal tip of the…
Editor's Note The Joint Commission announced April 21 that, effectively immediately, Life Safety Code surveyors will cite noncompliance in suites with aisles that have less than 36 inches of clearance from side to side to facilitate egress in hospitals and critical access hospitals. The finding will be scored at Life…
Editor's Note The Joint Commission, on April 14, announced that new Heads-Up Reports for first quarter 2021 are now available for all accredited programs. The downloadable report is posted in the “Resources and Tools” section of an organization’s secure Joint Commission Connect extranet site. Each report identifies important topics or…
